RecruitingNCT06730529
The Value of 68Ga-FAPI PET/CT in Preoperative Evaluation of Thyroid Cancer with Lymph Node Metastases
Sponsor
Ruijin Hospital
Enrollment
40 participants
Start Date
Nov 29, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to investigate the value of 68Ga-FAPI in the preoperative evaluation of thyroid cancer of different pathologic types.
Eligibility
Min Age: 16 YearsMax Age: 80 Years
Plain Language Summary
Simplified for easier understanding
This study is testing whether a special type of PET/CT scan using a tracer called 68Ga-FAPI can better detect how far thyroid cancer has spread to nearby lymph nodes before surgery. The goal is to help surgeons plan more precise operations.
**You may be eligible if...**
- You have been diagnosed with thyroid cancer that has spread to lymph nodes (confirmed by biopsy or imaging)
- You are between 16 and 80 years old
- You are willing to follow all study procedures
**You may NOT be eligible if...**
- You have serious heart, lung, bone marrow, liver, or kidney problems
- You have a bowel perforation or complete intestinal blockage
- You are pregnant, possibly pregnant, or breastfeeding
- You are unable or unwilling to follow the study procedures
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06730529
Related Trials
Studies on Tumors of the Thyroid
NCT000011601 location
DESTINY-PANTUMOUR04
NCT0712400017 locations
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
NCT057330131 location
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
NCT0553813077 locations
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
NCT069595111 location